Medisun Precision Medicine Ltd. (MPME) financial statements (2021 and earlier)

Company profile

Business Address TRUST COMPANY COMPLEX
MAJURO, MH96960
State of Incorp.
Fiscal Year End December 31
SIC 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,3371,812556818
Cash and cash equivalents1,3371,812556818
Other undisclosed current assets 200  
Total current assets:1,3372,012556818
Noncurrent Assets
Property, plant and equipment123166  
Intangible assets, net (including goodwill)1,025  94
Intangible assets, net (excluding goodwill)1,025  94
Other undisclosed noncurrent assets2602,068944 
Total noncurrent assets:1,4092,23494494
TOTAL ASSETS:2,7464,2461,500912
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:40181266210
Other undisclosed accounts payable and accrued liabilities40181266210
Debt499   
Due to related parties 14910530
Other undisclosed current liabilities (149)(105)(30)
Total current liabilities:539181266210
Noncurrent Liabilities
Other undisclosed noncurrent liabilities 384353350
Total noncurrent liabilities: 384353350
Total liabilities:539565619560
Stockholders' equity
Stockholders' equity attributable to parent, including:2,2073,681880353
Common stock1110
Additional paid in capital14,17212,6406,4251,162
Accumulated deficit(11,966)(10,092)(5,547)(810)
Other undisclosed stockholders' equity attributable to parent 1,1322 
Other undisclosed stockholders' equity  0 
Total stockholders' equity:2,2073,681880353
TOTAL LIABILITIES AND EQUITY:2,7464,2461,500912

Income statement (P&L) ($ in thousands)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
Operating expenses(1,660)(2,638)(4,700)(760)
Operating loss:(1,660)(2,638)(4,700)(760)
Nonoperating income
(Debt Instrument, Convertible, Beneficial Conversion Feature)
  20 
Interest and debt expense 145  
Loss from continuing operations before income taxes:(1,660)(2,493)(4,680)(760)
Income tax expense  (1,611) 
Net loss:(1,660)(2,493)(6,291)(760)
Other undisclosed net income (loss) attributable to parent(214)(71)1,553(11)
Net loss available to common stockholders, diluted:(1,874)(2,565)(4,738)(771)

Comprehensive Income ($ in thousands)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(1,660)(2,493)(6,291)(760)
Comprehensive loss, net of tax, attributable to parent:(1,660)(2,493)(6,291)(760)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: